Artificial intelligence to deep learning: machine intelligence approach for drug discovery

R Gupta, D Srivastava, M Sahu, S Tiwari, RK Ambasta… - Molecular …, 2021 - Springer
Drug designing and development is an important area of research for pharmaceutical
companies and chemical scientists. However, low efficacy, off-target delivery, time …

Artificial intelligence in drug discovery: recent advances and future perspectives

J Jiménez-Luna, F Grisoni, N Weskamp… - Expert opinion on drug …, 2021 - Taylor & Francis
Introduction: Artificial intelligence (AI) has inspired computer-aided drug discovery. The
widespread adoption of machine learning, in particular deep learning, in multiple scientific …

Investigating cardiotoxicity related with hERG channel blockers using molecular fingerprints and graph attention mechanism

T Wang, J Sun, Q Zhao - Computers in biology and medicine, 2023 - Elsevier
Human ether-a-go-go-related gene (hERG) channel blockade by small molecules is a big
concern during drug development in the pharmaceutical industry. Failure or inhibition of …

scAAGA: Single cell data analysis framework using asymmetric autoencoder with gene attention

R Meng, S Yin, J Sun, H Hu, Q Zhao - Computers in biology and medicine, 2023 - Elsevier
In recent years, single-cell RNA sequencing (scRNA-seq) has emerged as a powerful
technique for investigating cellular heterogeneity and structure. However, analyzing scRNA …

GraphDTA: predicting drug–target binding affinity with graph neural networks

T Nguyen, H Le, TP Quinn, T Nguyen, TD Le… - …, 2021 - academic.oup.com
The development of new drugs is costly, time consuming and often accompanied with safety
issues. Drug repurposing can avoid the expensive and lengthy process of drug development …

HINGRL: predicting drug–disease associations with graph representation learning on heterogeneous information networks

BW Zhao, L Hu, ZH You, L Wang… - Briefings in …, 2022 - academic.oup.com
Identifying new indications for drugs plays an essential role at many phases of drug
research and development. Computational methods are regarded as an effective way to …

MRMD2. 0: a python tool for machine learning with feature ranking and reduction

S He, F Guo, Q Zou - Current Bioinformatics, 2020 - ingentaconnect.com
Aims: The study aims to find a way to reduce the dimensionality of the dataset. Background:
Dimensionality reduction is the key issue of the machine learning process. It does not only …

COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel …

B Robson - Computers in biology and medicine, 2020 - Elsevier
This paper continues a recent study of the spike protein sequence of the COVID-19 virus
(SARS-CoV-2). It is also in part an introductory review to relevant computational techniques …

ToxIBTL: prediction of peptide toxicity based on information bottleneck and transfer learning

L Wei, X Ye, T Sakurai, Z Mu, L Wei - Bioinformatics, 2022 - academic.oup.com
Motivation Recently, peptides have emerged as a promising class of pharmaceuticals for
various diseases treatment poised between traditional small molecule drugs and therapeutic …

Geometric interaction graph neural network for predicting protein–ligand binding affinities from 3d structures (gign)

Z Yang, W Zhong, Q Lv, T Dong… - The journal of physical …, 2023 - ACS Publications
Predicting protein–ligand binding affinities (PLAs) is a core problem in drug discovery.
Recent advances have shown great potential in applying machine learning (ML) for PLA …